Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma
- Resource Type
- article
- Authors
- Falk Rauchfuß; Aladdin Ali-Deeb; Oliver Rohland; Felix Dondorf; Michael Ardelt; Utz Settmacher
- Source
- Current Oncology, Vol 29, Iss 3, Pp 1932-1938 (2022)
- Subject
- living donation
malignancy
hepatobiliary disease
transplant oncology
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
- Language
- English
- ISSN
- 1718-7729
1198-0052
Intrahepatic cholangiocarcinoma is in most transplant regions a contraindication for liver transplantation, even ruling out an active waiting list registration. However, recent studies showed that well-selected patients after a neo-adjuvant treatment benefit from liver transplantation with good long-term outcomes. The role of living donor liver transplantation is unclear for this indication. The current study focuses on LDLT for intrahepatic cholangiocarcinoma.